Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions (original) (raw)

Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone

Thomas Lennard

The Women's Oncology Review, 2005

View PDFchevron_right

Fibroblast growth factors signaling in bone metastasis

Elba Vazquez

Endocrine-Related Cancer, 2020

View PDFchevron_right

Transforming growth factor-β signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation

Rakesh Singh

Cancer Science, 2009

View PDFchevron_right

Transforming growth factor-β1 is the predominant isoform required for breast cancer cell outgrowth in bone

Anna Mourskaia, Zhifeng Dong

Oncogene, 2009

View PDFchevron_right

Altered immunolocalization of FGF23 in murine femora metastasized with human breast carcinoma MDA-MB-231 cells

Shinichiro Kuroshima

Journal of Bone and Mineral Metabolism, 2021

View PDFchevron_right

TGF-β in the Bone Microenvironment: Role in Breast Cancer Metastases

Jeroen Buijs

View PDFchevron_right

Role of TGF-β in breast cancer bone metastases

Antonella Chiechi

Advances in bioscience and biotechnology (Print), 2013

View PDFchevron_right

Breast Cancer-derived Factors Stimulate Osteoclastogenesis through the Ca2+/Protein Kinase C and Transforming Growth Factor-β/MAPK Signaling Pathways

Osama Hussein

Journal of Biological Chemistry, 2009

View PDFchevron_right

Decreased Autocrine EGFR Signaling in Metastatic Breast Cancer Cells Inhibits Tumor Growth in Bone and Mammary Fat Pad

Khalid Mohammad

PLoS ONE, 2012

View PDFchevron_right

McLeskey SW, Ding IYF, Lippman ME, Kern FGMDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor receptors and are growth inhibited by FGF ligands. Cancer Res 54: 523-530

Marc Lippman

Cancer Research

View PDFchevron_right

Functional interaction of fibroblast growth factor-8, bone morphogenetic protein and estrogen receptor in breast cancer cell proliferation

Tadahiko Shien

Molecular and Cellular Endocrinology, 2011

View PDFchevron_right

Therapeutic targets for bone metastases in breast cancer

Philippe Clézardin

Breast Cancer Research, 2011

View PDFchevron_right

Pre-Osteoblasts Stimulate Migration of Breast Cancer Cells via the HGF/MET Pathway

Stefano Malvestiti

PloS one, 2016

View PDFchevron_right

MDA-MB-134 Breast Carcinoma Cells Overexpress Fibroblast Growth Factor (FGF) Receptors and Are Growth-inhibited by FGF Ligands 1

Francis Kern

Cancer Research, 1994

View PDFchevron_right

Inhibition of Platelet-Derived Growth Factor Receptor Signaling Restricts the Growth of Human Breast Cancer in the Bone of Nude Mice

Sertac Yazici

Clinical Cancer Research an Official Journal of the American Association For Cancer Research, 2005

View PDFchevron_right

Early TGF-β inhibition in mice reduces the incidence of breast cancer induced bone disease in a myeloid dependent manner

Julie Sterling

Bone, 2018

View PDFchevron_right

Tumor-Stroma Crosstalk in Bone Tissue: The Osteoclastogenic Potential of a Breast Cancer Cell Line in a Co-Culture System and the Role of EGFR Inhibition

Toni Ibrahim

International Journal of Molecular Sciences, 2017

View PDFchevron_right

An Osteoblast-Derived Proteinase Controls Tumor Cell Survival via TGF-beta Activation in the Bone Microenvironment

Daniel Rifkin

PLoS ONE, 2012

View PDFchevron_right

Bone Metastasis Phenotype and Growth Undergo Regulation by Micro-Environment Stimuli: Efficacy of Early Therapy with HGF or TGFβ1-Type I Receptor Blockade

Valentina Dall'Olio

International Journal of Molecular Sciences, 2019

View PDFchevron_right

Differential Gene Expression of TGF-β Family Members and Osteopontin in Breast Tumor Tissue: Analysis by Real-Time Quantitative PCR

Patrick Roche

Breast Cancer Research and Treatment, 2002

View PDFchevron_right

The Effects of TGF-β Signaling on Cancer Cells and Cancer Stem Cells in the Bone Microenvironment

Mitsuru Futakuchi

International Journal of Molecular Sciences, 2019

View PDFchevron_right

Regulation of Osteoblast Differentiation: A Novel Function for Fibroblast Growth Factor 8

Teuvo A Hentunen

Endocrinology, 2006

View PDFchevron_right

Conditional Activation of Fibroblast Growth Factor Receptor (FGFR) 1, but not FGFR2, in Prostate Cancer Cells Leads to Increased Osteopontin Induction, Extracellular Signal-regulated Kinase Activation, and in Vivo Proliferation1

Rama Gangula, Kevin Freeman

Cancer Research, 2003

View PDFchevron_right

Advances in the biology of bone metastasis: How the skeleton affects tumor behavior

Julie Sterling

Bone, 2011

View PDFchevron_right

MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands

Francis Kern

Cancer research, 1994

View PDFchevron_right

Localization of osteoblast inflammatory cytokines MCP-1 and VEGF to the matrix of the trabecula of the femur, a target area for metastatic breast cancer cell colonization

Neil Sharkey

Clinical & Experimental Metastasis, 2010

View PDFchevron_right

Mechanisms of bone metastases of breast cancer

Robert Griffin

Endocrine Related Cancer, 2009

View PDFchevron_right

Osteoblast-conditioned medium promotes proliferation and sensitizes breast cancer cells to imatinib treatment

Lucio Gnessi

Endocrine Related Cancer, 2007

View PDFchevron_right

Cellular mechanisms of bone resorption in breast carcinoma

Afsie Sabokbar

British Journal of Cancer, 2001

View PDFchevron_right

Contribution of Bone Tissue Modulus to Breast Cancer Metastasis to Bone

Scott Guelcher

Cancer Microenvironment, 2011

View PDFchevron_right

Basic fibroblast growth factor autocrine loop controls human osteosarcoma phenotyping and differentiation

Lilla Maria Crisafulli

Molecular medicine (Cambridge, Mass.), 2002

View PDFchevron_right

Human Amniotic Tumor That Induces New Bone Formation in Vivo Produces a Growth-regulatory Activity in Vitro for Osteoblasts Identified as an Extended Form of Basic Fibroblast Growth Factor

Colin Dunstan

Cancer Research, 1996

View PDFchevron_right

Bone Structural Components Regulating Sites of Tumor Metastasis

Scott Guelcher

Current Osteoporosis Reports, 2011

View PDFchevron_right

Therapeutic and Preventive Effects of Osteoclastogenesis Inhibitory Factor on Osteolysis, Proliferation of Mammary Tumor Cell and Induction of Cancer Stem Cells in the Bone Microenvironment

Mitsuru Futakuchi

International journal of molecular sciences, 2018

View PDFchevron_right